HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investors Call For Greater Safety Disclosure To Protect Cosmetics Market

This article was originally published in The Rose Sheet

Executive Summary

On the heels of a push by activist groups to take beauty companies to task for suspected toxins in their products, the Investor Environmental Health Network (IEHN) asks that companies avoid market disruptions by eliminating harmful ingredients

You may also be interested in...



Five Years After "Milestone" Nanotech Report, Same Concerns Remain

Opinion leaders agree that many of the concerns raised about nanotechnology in a July 2004 report from the UK-based Royal Society/Royal Academy of Engineering are just as relevant today, pointing to a need for action rather than mere strategizing

Five Years After "Milestone" Nanotech Report, Same Concerns Remain

Opinion leaders agree that many of the concerns raised about nanotechnology in a July 2004 report from the UK-based Royal Society/Royal Academy of Engineering are just as relevant today, pointing to a need for action rather than mere strategizing

Resolution Urging Firms To Share Nanotech Policy Shows Investor Awareness

A shareholder resolution set before Avon and Colgate-Palmolive by the Calvert Group reflects the investment community's growing awareness of nanotechnology and its potential liabilities

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014571

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel